MorphoSys shares jump on expanded antibody discovery deal with Novartis; Pfizer, Auxilium wrap Xiaflex collaboration; New biomarker for diabetes risk;

Conversation on Twitter :

Biotech News

 @FierceBiotech: Test could detect a range of cancers weeks before symptoms. More | Follow @FierceBiotech

 @JohnCFierce: Are clinical trial investigators guilty of mission creep? Report | Follow @JohnCFierce

 @RyanMFierce: Maverix enters genomics software game with Silicon Valley sizzle. More | Follow @RyanMFierce

> Shares of MorphoSys AG got a boost after the biotech announced that it would expand its antibody discovery pact with Novartis ($NVS). The financial terms were not disclosed. Story

> Auxilium and Pfizer ($PFE) are wrapping up their EU collaboration on the Dupuytren's treatment Xiaflex, with marketing rights reverting back to Auxilium. Report

> Vectura filed its marketing application for the COPD drug QVA149 in Japan. Story

Pharma News

@FiercePharma: Are you ready, Humira? Pfizer nabs FDA blessing for blockbuster hopeful Xeljanz, for rheumatoid arthritis. Story | Follow @FiercePharma

> Roche's souped-up breast cancer drug steps on FDA fast track. Item

> Obama's re-elected. So what's next for pharma? Story

> Exec says GSK is back on the straight and narrow. Report

Medical Device News

 @FierceMedDev: BSX study shows improved defibrillator programming reduces unnecessary jolts as well as risk of death. More | Follow @FierceMedDev

 @MarkHFierce: BD ended its 2012 fiscal year on a down note. But CE Forlenza qualifies it as a "solid finish." News | Follow @MarkHFierce

 @DamianFierce: Medical device manufacturer Onyx got snapped up for $43.25M by Sparton. Story | Follow @DamianFierce

> Mindray tanks on disappointing Q3. Article

> Medtronic-backed study supports greater use of CRT pacemakers. Story

> Study: Valves & stents often win FDA nod without proving they improve care. Item

Drug Delivery News

> Hydrogel time bombs set off explosive drug release. Story

> Novartis submits COPD combination inhaler in Japan. Item

> $1M Gates Foundation grant to formulate lifesaving oxytocin. News

Biomarkers News

> Bowel cancer biomarkers from Down Under catch U.S. attention. Item

> Blood protein tags progression in ALS. Article

> Phase III finding points to masitinib CDx for pancreatic cancer. Story

> Breast cancer biomarkers predict tamoxifen response. Report

> Simple blood count points to survival in aggressive skin cancer. News

And Finally… Investigators say that a protein called SFRP4 in the blood can serve as an efficient biomarker to flag a high risk of diabetes. Release


Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.